The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, with a simultaneous closing to ...

Keystone Folding Box Co., a provider of paperboard packaging solutions, has partnered with Med-Con Technologies, a provider ...

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

ProFound Therapeutics, a company pioneering the expanded human proteome to develop medicines, has announced a four-year ...

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...

© Vetter Pharma International GmbH: Vetter marks the start of new clinical site construction with groundbreaking ceremony.

Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...